Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

SODIUM CHLORIDE INJECT

Active
SPE2DP-26-T-4198Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Sodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.

General Info

Baxter Healthcare supplies sterile sodium chloride injection under NSN 6505014622120, FOB destination, 1 PG, 15-month shelf life, DLA-compliant.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

BLDG 63 EAST CAMP DRIVE, SEA GIRT, NJ, 08750-0000, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4198 Medical Supply Chain Pharm FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
SODIUM CHLORIDE INJECTION
SODIUM CHLORIDE INJ
indicated as a source of water and electrolytes; sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents; UOI EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE (25 C/77 F) UNTIL READY TO USE AVOID EXCESSIVE HEAT;
SHALL HAVE A SHELF LIFE OF 15 MONTHS. NOT MORE THAN 2 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE GOVERNMENT. RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
SPE2DP-26-T-4198
SECTION B
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORPORATION 1G026 P/N 2B1313Q
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017534854 0001 PG 1.000
NSN/MATERIAL:6505014622120
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-462-2120 Quantity: 1 PG Purchase Request: 7017534854QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
DOCOSANOL CREAMDocosanol Cream 10% in 2gm tubes is procured under solicitation SPE2DP-26-T-4191 for treatment of herpes simplex virus type 1, specifically for cold sores or fever blisters on the face or lips, and is intended for use by adults and children 12 years of age and older. The product must be stored at 20°C to 25°C (68°F to 77°F) and must not be frozen. The National Stock Number is 6505-01-724-6160 and the unit of issue is the tube (TU). The contract is structured across five CLINs with quantities totaling 37 tubes allocated across multiple delivery points, including Fort Carson, Colorado and Fort Bragg, North Carolina. Delivery is required within 20 days of order placement with specific deadlines ranging from April to May 2026 and all shipments are FOB destination with zero variance allowed on quantity. The product is regulated by the FDA and requires a referral to the product specialist via EBS for confirmation prior to award, including bidder and manufacturer details. Medical Marking Standard No. 1 supersedes MIL-STD-129 for all marking requirements, and packaging must follow MIL-STD-2073-1E with commercial packaging methods ensuring protection against damage. Palletization must conform to DLA Packaging Requirements (RP001). The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) item. Shipment must be via traceable means and parcel post is prohibited. All offers must be submitted electronically through the DLA Internet Bid Board System (DIBBS) with a deadline of July 27, 2026. The contract incorporates multiple FAR and DFARS clauses including those on cybersecurity, trafficking in persons, employment verification, hazardous materials, and protection of covered defense information. The contractor is required to comply with all applicable safeguarding standards and provide hazard warning labels and safety data sheets if applicable. Payment is processed through Wide Area WorkFlow and no unit prices are disclosed within the solicitation document.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
IODINE SOLUTION, STRONGThe contract specifies the procurement of Iodine Solution, Strong, formally known as Lugol’s Solution 5 Percent, packaged in a 500ml amber glass bottle containing 5 percent iodine and 10 percent potassium iodide. The item is designated with NSN 6505-01-706-4127 and is to be delivered in a single unit, with no quantity variance allowed, under a firm delivery deadline of 20 days from contract award. Packaging must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed in commercial containers designed to prevent damage or breakage during transit. The shipment must be transported using the lowest-cost carrier while ensuring safe and accepted delivery to the designated destination in APO AE 09853, with explicit prohibition against parcel post; fastest traceable freight methods are required. The item carries a non-extendable shelf life of 60 months as a TYPE I (Code S) item, and all packaging and marking must adhere to DLA packaging requirements and applicable medical standards. Delivery is FOB destination, with inspection and acceptance occurring upon arrival, and the supplier is required to meet technical and quality specifications referenced in the DLA Master List. The contract is issued under solicitation SPE2DP-26-T-4152, with a required delivery date of July 16, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

6 days ago

DEADLINE

in about 11 hours
View Details
NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINEKetorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

6 days ago

DEADLINE

in about 22 hours
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency